MannKind Corp
MNKD
#6217
Rank
NZ$1.57 B
Marketcap
NZ$5.10
Share price
-3.24%
Change (1 day)
-32.28%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): NZ$2.84 Million

According to MannKind Corp's latest financial reports the company's current earnings are NZ$0.34 Billion. a decrease over its 2024 earnings that were of NZ$52.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 NZ$2.4 M-95.39%
2024 NZ$52.09 M-394.09%
2023 -NZ$17.72 Million-88.13%
2022 -NZ$0.15 Billion8%
2021 -NZ$0.14 Billion40.84%
2020 -NZ$98.09 Million10.7%
2019 -NZ$88.6 Million-40.16%
2018 -NZ$0.15 Billion-26.04%
2017 -NZ$0.21 Billion-193.33%
2016 NZ$0.21 B-134.11%
2015 -NZ$0.63 Billion85.72%
2014 -NZ$0.34 Billion3.6%
2013 -NZ$0.33 Billion12.79%
2012 -NZ$0.29 Billion5.58%
2011 -NZ$0.28 Billion-5.72%
2010 -NZ$0.3 Billion-22.51%
2009 -NZ$0.38 Billion-27.37%
2008 -NZ$0.52 Billion3.36%
2007 -NZ$0.51 Billion27.18%
2006 -NZ$0.4 Billion101.63%
2005 -NZ$0.2 Billion50.46%
2004 -NZ$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.07 B 752,636.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$42.69 B 1,777,575.91%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$53.13 B 2,212,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.45 B 934,654.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$0.79 B 33,082.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.27 Billion-11,150.96%๐Ÿ‡บ๐Ÿ‡ธ USA